Rocket Lab Stock Climbs 29% On A 6-Day Winning Streak
A streak in the aerospace name is drawing attention, but the underlying numbers present a more complicated picture.
Rocket Lab (RKLB) stock has now moved higher for 6 consecutive trading days, posting a cumulative gain of 29%. That run has added about $10 billion to the company’s market value, which now stands at about $46 billion.
For existing shareholders, the sharp uptick is a temporary reprieve within a broader multi-month decline. The question is what the data says about the new valuation.
RKLB Versus The S&P 500, Streak And Beyond
- Broadcom Stock: 7 Straight Green Days, Up 16%
- Verizon Communications Was The Bargain A Year Ago. Now It Carries The Premium Over AT&T
- Cisco Stock Is Finally Pricing In A New Growth Story
- PYPL Showered Owners With Cash. The Stock Still Lagged The Market
- META Stock Returns To Familiar Ground
- UNH Leads Its Peer Group. You Pay For That
Here is how RKLB stock stacks up against the S&P 500 over the streak and the periods around it:
| Return Period | RKLB | S&P 500 |
|---|---|---|
| 1D | 1.1% | -0.2% |
| 6D (Current Streak) | 29.1% | 5.4% |
| 1M (21D) | -9.2% | 3.0% |
| 3M (63D) | -10.6% | 4.7% |
| YTD 2026 | 8.5% | 12.6% |
| 2025 | 173.9% | 16.4% |
| 2024 | 360.6% | 23.3% |
| 2023 | 46.7% | 24.2% |
What Do the Numbers Say About This Run?
The move is largely specific to Rocket Lab; over the same 6 trading days the S&P 500 returned +5.4%. The market appears to be weighing a business with rapid expansion against significant losses. Revenue over the last twelve months grew 45.8%, far outpacing the S&P 500 median revenue growth of 7.9%.
However, the company’s operating margin over the last twelve months is -33.2%, compared to an S&P 500 median of 18.5%. RKLB also has negative trailing earnings. While such streaks are not unheard of, 51 S&P 500 stocks are currently on winning streaks of 3 days or more, the fundamental picture for Rocket Lab is one of high growth paired with deep unprofitability.
So How Should I Treat This Information?
A streak is a data point about momentum and investor attention, not a direct instruction to buy or sell. The market is clearly focused on the company’s story right now, but a rising price does not change the underlying business facts.
The disciplined approach is to use the new price as a prompt. It is an opportunity to re-evaluate whether the company’s growth prospects justify its current valuation, especially when measured against its lack of profitability. The numbers provide a starting point for that work.
A run like this is worth respecting, and worth testing: the momentum that lasts is usually the kind management itself is underwriting. Our Guidance Momentum screen tracks the stocks whose companies just raised their own forward numbers.
And for anyone who would rather back the theme than one company’s story, an aerospace & defense ETF like MISL owns the whole group. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
Momentum Is A Tailwind, Not A Plan
Riding a stock that rises every day feels effortless, and that is precisely the danger: the same momentum that built this run can reverse without notice, and one name’s reversal should never be able to reset your whole year.
That is what the Trefis High Quality (HQ) Portfolio is for: about 30 quality businesses screened for the fundamentals that survive momentum’s mood swings, held with rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Watch the runs; own the resilience.